Clinical Neuroscience

[Dear Colleagues!]

RAJNA Péter, BÉKÉS Judit, HALÁSZ Péter, JUHOS Vera

NOVEMBER 20, 2012

Clinical Neuroscience - 2012;65(11-12)

COMMENTS

0 comments

Further articles in this publication

Clinical Neuroscience

[Account on the scientific meeting of Környey Society in 2012]

KOPA János

Clinical Neuroscience

[Rivaroxaban in prevention of stroke in patients with atrial fibrillation]

SIMONYI Gábor, MEDVEGY Mihály

[Atrial fibrillation (AF) is well established risk factor for cardioembolic stroke. With thromboprophylatic treatment we can reduce the risk of stroke in patients with AF. Oral vitamin K antagonists (VKA) such as warfarin and acenocoumarol are effective for stroke prevention in patients with atrial fibrillation. VKAs are associated with several limitations including very narrow therapeutic range, several factors (diet, drugs, alcohol consumption) affecting the effect of VKA and excessive bleeding may occur if INR value not controlled successfully. New oral anticoagulant direct Xa factor inhibitor rivaroxaban has a good therapeutic efficacy in prevention (primary and secondary) of stroke in AF patients. Its advantages are including no need for monitoring, fixed oral dose, not affected by meal, age and body weight, all of them can improve patient adherence. In ROCKET AF trial in patients with AF, rivaroxaban was noninferior to warfarin for the prevention of stroke or systemic embolism. There was no significant between-group difference in the risk of major bleeding, although intracranial and fatal bleeding occurred less frequently in the rivaroxaban group.]

Clinical Neuroscience

[New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimode]

KOMOLY Sámuel

Clinical Neuroscience

[Aspirin and clopidogrel resistance: possible mechanisms and clinical relevance. Part I: Concept of resistance]

VADÁSZ Dávid, SZTRIHA K László, SAS Katalin, VÉCSEI László

[Aspirin and clopidogrel are well established as antiplatelet medication in the treatment of atherothrombotic vascular disease. However, despite treatment, a substantial number of patients experience recurrent ischemic episodes, referred to as aspirin or clopidogrel treatment failure. Various laboratory techniques are available with which to evaluate the effectiveness of antiplatelet drugs. Interestingly, the agreement between the results of the different tests may be poor. The term aspirin or clopidogrel resistance denotes those conditions in which an inadequate inhibitory efficacy of the given antiplatelet agent is detected by an in vitro assay of platelet function. It has been estimated that on average some 30% of patients treated with aspirin, and 20% on clopidogrel, do not achieve an appropriate level of efficacy as concerns platelet activity.]

Clinical Neuroscience

[Meeting of the management of Hungarian Epilepsy League]

All articles in the issue

Related contents

Ca&Bone

[Dear Colleagues and Readers!]

HORVÁTH CSABA

Journal of Nursing Theory and Practice

[The role of nurses in the clinical trials]

NAGY Mónika Anita

[Aim of the research: To assess the occupational duties and responsibilities of nurses in relation to clinical trials in Hungary. Research and sampling methods: Self-administered questionnaire was used among the colleagues working in the field of clinical trial and IBM SPSS 22.0 software using descriptive statistical methods was performed. Results: It was found that the majority of nurses complete the duties of a study coordinator and the task of a study nurse simultaneously. They were involved in everyday activities that characterise the assistance of patients and in the management of paper-based documentation during clinical trials. Lack of knowledge in English language was identified for the reason of reduced-functionality of nurses in 59 cases. Conclusions: nurses have complex responsibilities, although they meet the requirements when it comes to the professional tasks and documentation obligations, but in the case of more complicated professional challenges nurses get fewer opportunities, mainly because of their poor English skills.]

Hypertension and nephrology

[The history of diuretic treatment in Hungary. Part I. Imre Fodor]

RADÓ János

[The diuretic effect of mercurial compounds was discovered in 1920. However, the term of “mercurial diuresis” was created 36 years earlier by Ernő Jendrassik. Imre Fodor published his experiences with the mercurial diuretic, which has been cited by several authors worldwide. The Hungarian pharmaceutical industry also took its part from the production of the mercurial diuretic with Novurit that proved to be an excellent and worldwide well known preparation in the next 40 years. Even Imre Fodor required the repeated administration of mercurial diuresis because of his severe cardiac oedema in the last period of his life. When the drug became ineffective, i.e. developed refractory oedema, he made a “self-experiment” with the administration of ACTH to restore the sensitiveness to the mercurial diuretic on the basis of most recent American literature at that time. His experience has been published by his colleagues just before his death. Imre Fodor was an eminent clinician, a school creating internist who entered his name into the science dealing with the use of diuretics.]

Ca&Bone

[Dear Colleagues and Readers!]

HORVÁTH CSABA

Ca&Bone

[Dear Readers! Dear Colleagues!]

HORVÁTH CSABA